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Abstract Despite its medical applications, the mecha-
nisms responsible for the osseointegration of bioactive
glass (45S5) have yet to be fully understood. Evidence
suggests that the strongest predictor for osseointegration of
bioactive glasses, and ceramics, with bone tissue as the
formation of an apatitic calcium phosphate layer atop
the implanted material, with osteoblasts being the main
mediator for new bone formation. Most have tried to
understand the formation of this apatitic calcium phosphate
layer, and other bioresponses between the host and bioac-
tive glass 45S5 using Simulated Body Fluid; a solution
containing ion concentrations similar to that found in
human plasma without the presence of proteins. However,
it is likely that cell attachment is probably largely mediated
via the adsorbed protein layer. Plasma protein adsorption at
the tissue bioactive glass interface has been largely over-
looked. Herein, we compare crystalline and amorphous
bioactive glass 45S5, in both melt-derived as well as sol–
gel forms. Thus, allowing for a detailed understanding of
both the role of crystallinity and powder morphology on
surface ions, and plasma protein adsorption. It was found
that sol–gel 45S5 powders, regardless of crystallinity,
adsorbed 3–5 times as much protein as the crystalline melt-
derived counterpart, as well as a greater variety of plasma
proteins. The devitrification of melt-cast 45S5 resulted in
only small differences in the amount and variety of the
adsorbed proteome. Surface properties, and not material
crystallinity, play a role in directing protein adsorption
phenomena for bioactive glasses given the differences
found between crystalline melt-cast 45S5 and sol–gel
derived 45S5.
1 Introduction
Bioactive glasses, specifically ceramic Bioglass formu-
lation 45S5 (45 %SiO2, 24.5 %Na2O, 24.5 %CaO, and
6 % P2O5 by weight), have garnered serious attention as a
functional biomaterial due to its ability to integrate with
bone. Previous work has shown that bioactive glass 45S5
can be inserted into areas of large scale bone damage to
help augment its repair, while providing structural support
by binding strongly to endogenous bone [1–3]. This
material is capable of interacting with the surrounding
tissue milieu, and has been shown to serve as a substrate on
which osteogenic stem cells can attach and differentiate
[2–8]. Moreover, bioactive glasses have been used for several
clinical applications, such as ossicular implantation for
alleviating conductive hearing loss, as dental implants for
maintaining the endosseous ridge before dentures are fitted,
and as a particulate for augmenting the natural repair
process in patients with periodontal disease [9]. Besides
improving the mechanical properties of the final material,
leading to its application to a broader range of clinical
applications, inducing crystallinity in bioactive glasses may
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affect the mineral formation rate and bone integration at
the tissue-material interface [10–12]. Nonetheless, clear
evidence implicates the strongest predictor for osseointe-
gration of bioactive glasses and ceramics with bone tissue
as the formation of an apatitic calcium phosphate layer
atop the implanted material, as aptly reviewed elsewhere
[13]. Wherein, strong in vivo evidence suggests that oste-
oblasts, in the presence of an apatitic calcium phosphate
layer, attach and proliferate to form new bone. Most work
in the field has tried to model the interaction between the
host and bioactive glass 45S5 using Simulated Body Fluid
(SBF) rather than in vivo testing. Kokubo and Takadama
posit that a particular concentration of ions in a simulated
body fluid (SBF, with ion concentrations similar to those
found in human plasma) may be useful in predicting in
vivo bone formation if an apatitic calcium phosphate layer
forms on the surface of the bioactive glass after immersion
in the SBF [13]. The situation is of course more compli-
cated: cells may not directly attach to these surfaces, rather
cell attachment may largely be mediated via adsorbed
proteins, and SBF contains no proteins. It appears that the
adsorption of proteins at the tissue bioactive glass interface
has been largely overlooked regarding proxy tests for in
vivo animal implantation and histology.
The crystallinity and the manufacturing method of 45S5
are thought to have significant effects on this material
[11, 12]. Many studies have investigated the effect of
devitrifying bioactive glasses, to move from an amorphous
to ceramic glass (crystalline or semi-crystalline), so as to
optimize the required parameters of bioactive materials for
application in the medical industry: with a special emphasis
on bone growth [14–16]. Bioactive glass 45S5 transforms
to a glass ceramic with crystalline phase Na2Ca2Si3O9
(combeite) by heating the material at 700 C for more than
0.5 h [17, 18]. Crystallization of the bioactive glass results
in improved mechanical properties and allows for powder
sintering. Despite these benefits, glass ceramics (crystalline
or semi-crystalline) can show less solubility in body fluid
and, thus, may dramatically affect the protein adsorption
profile. Various mechanisms for such in vitro and in vivo
behavioural differences have been proposed. A common
argument is that the phosphorous concentration and dis-
tribution changes upon crystallization of a glass, and thus
the phosphorous dissolution profile changes, which ulti-
mately affects the time to form a mineral phase suitable for
tissue integration (i.e., hydroxycarbonate apatite, HCA).
For example, crystalline ceramics of the same starting
composition require three times as much time to form HCA
compared to amorphous counterparts [12]. Such a time
limitation to form HCA for crystalline ceramics can be
overcome by increasing the surface area of the material by
using an alternate manufacturing method [19] in order to
change the ‘‘texture’’ of the ceramic [20]. As opposed to
the dense surface structure created via traditional melt
casting methods, the sol–gel method is a widely used
production technique that yields a highly porous material
structure, which could lead to higher apparent dissolution
rates (higher surface area to volume ratio) [21].
The interactions of bioactive glass ceramics with the
host environment have been characterized using either
SBF or cell studies. SBF is an acellular solution designed
to mimic the ionic concentrations of various elements
found in human plasma including Na?, Mg2?, Ca2?, Cl-,
HCO3
- and HPO4
2- [22]. However, it lacks other plasma
components such as dissolved nutrients, vitamins, tri-
glycerides, cholesterols and proteins. This omission may
be why cell studies with bioactive glasses show results
ranging from enhancement of bone repair to inhibition of
the same process [23–27]. While proteins make up less
than 10 % of human plasma, their effects on host
response can outweigh any effect elicited by a change in
ion concentration. The adsorption of a protein layer to a
biomaterial surface takes mere seconds, but this adsorbed
layer directs any host responses such as platelet activa-
tion, coagulation, complement and immune responses as
well as any interactions between cells and the biomaterial
[28].
It has been shown in the literature that the presence of
proteins can affect 45S5 bioactive glass reactions yet the
interactions of plasma proteins with 45S5 bioactive glass
have not been studied in depth. Most studies make use of
either single or double protein solutions or do not attempt
to identify which proteins adsorb to the bioactive glass
surface [23, 29, 30]. Understanding the complex adsorp-
tion phenomena and their effects on host response is
critical to our understanding of all bioactive glasses,
including 45S5. To this end, this study will examine the
adsorption of proteins from platelet-poor human plasma to
most accurately simulate the adsorption effects seen when
the bioactive glass is used in medical applications. Fur-
thermore, immunoblots will be used to reliably identify
the types of proteins found eluted off of the surfaces down
to picomolar concentrations. The consequences of chan-
ges in bioactive glass formulations as well as any
underlying crystalline domains may alter plasma protein
adsorption and also need to be understood. This knowl-
edge is important not only for the development of bio-
active glasses, but because of 45S5’s clinical successes,
the plasma adsorption information can be used in the
development of a generalized model of plasma protein
adsorption to all biomaterial surfaces.
In this study a comparison of the protein absorption
from human blood plasma to melt-cast 45S5 (amorphous
and crystalline), with gel-derived 45S5 (crystalline), has
been carried out. It was found that the gel-derived glass had
about twice the specific surface area (using BET-N2
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adsorption techniques) of the cast samples due to the
submicron porosity demonstrated by SEM. XPS analysis
showed there was a difference in surface compositions
between the amorphous and crystalline samples but the
surface charges for each sample were all around -15 mV.
The sol–gel bioactive glass eluted 3–5 times more protein
than the cast samples and also showed a greater variety of
plasma proteins in the adsorbed proteome. It appears that
the atomic surface composition of the materials has a
greater effect on protein adsorption than net charge, as well
as material crystallinity.
2 Materials and Methods
2.1 Materials
Bioactive glass 45S5 prepared by two separate manufac-
turing routes (melt and sol–gel derived) was used in this
study. Melt-derived bioactive glass 45S5 powder (\20 lm)
was furnished by Mo-Sci Corporation (Missouri, USA).
Two versions of melt-derived 45S5 were used: amorphous
(as received) and crystalline (devitrified). Crystalline 45S5
was prepared by heat treating amorphous glass powder at
720 C for 20 min which resulted in 100 % crystalline
45S5.
Sol–gel derived glasses were prepared according to the
following procedure to prepare 20 g of powder. 3.26 mL of
69 % nitric acid was added to 47.6 mL of water to create a
1 M nitric acid solution. 0.15 mol (33.5 mL) tetraethylor-
thosilicate (TEOS, Sigma Aldrich, US) was added to the
1 M nitric acid for a final H2O: TEOS molar ratio equal to
18. The precursor hydrolysis was performed for 60 min
with stirring. The following reagents were allowed to react
for 45 min during stirring in the following sequence:
0.017 mol (2.9 mL) triethylphosphate (TEP, Sigma Aldrich,
US), 0.085 mol (20.13 g) calcium nitrate tetrahydrate
(Sigma Aldrich, US), and 0.16 mol (13.52 g) sodium
nitrate (Sigma Aldrich, US). The prepared transparent
solution was stored in a sealed Teflon container for 5 days
at ambient temperature to allow gel formation. The gel was
aged for 24 h at 70 C then dried at 120 C for 24 h.
Finally the dried sample was stabilized in a high alumina
crucible at 700 C using a benchtop muffle furnace
(Thermo scientific, F48055-60) for 24 h to remove residual
nitrates. The prepared powder was ground using a plane-
tary ball-mill at 500 rpm for 10 min with a spherical zir-
conia media (2 mm dia.) in ethanol to reduce the particle
size to 5–15 lm in order to be comparable to that of the
melt-cast powders. Measurement of particle size was car-
ried out by photon correlation spectroscopy [31]. The
average median diameter of melt cast and gel-derived
powders were 8.0 and 11.8 lm, respectively.
2.2 Surface Area Measurement
The surface areas of the powders were measured using a
Quantochrome Autosorb MP1 (Florida, USA) automatic
gas absorption system. The measurements were carried out
using nitrogen isotherms at 77 K. The point BET method
(0.05, 0.075, 0.1, 0.15, 0.25 and 0.3 mm Hg) was used to
analyze data. All the samples were degassed at 200 C,
under vacuum, for 3–4 h prior to the tests. All values
returned using the BET method have an associated error of
5 %.
2.3 Scanning Electron Microscopy
A JEOL 6301F scanning electron microscope (SEM,
Tokyo, Japan) was used to image the morphology of the
powder particles. Samples were coated with chromium to
achieve the highest conductivity with the least charging
(Edwards XE200, Xenosput, Australia). A 5 kV acceler-
ating voltage was also used to minimize charging.
2.4 X-ray Diffraction
A Rigaku Rotaflex Diffractometer (Woodlands, TX, USA)
was used to carry out X-ray diffraction (XRD) to charac-
terize the powder morphology and identify the presence of
crystalline phases after devitrification of bioactive glass.
The diffractometer was operated at 40 kV and 110 mA (Cu
target) at 2h range of 10–110 with a step size of 0.02.
2.5 Zeta-Potential Analysis
The electrophoretic mobility of the bioactive glass samples
was measured using the Nano-ZS instrument (Malvern
Instruments Ltd., UK) at 25 C in order to determine their
surface charges. If necessary, samples were diluted with
1 mM NaCl solution.
2.6 X-ray Photoelectron (XPS) Analysis
The XPS measurements were performed using an AXIS
165 spectrometer (Kratos Analytical) at the Alberta Centre
for Surface Engineering and Science (University of
Alberta). The base pressure in the analytical chamber was
lower than 3 9 10-8 Pa. A monochromatic Al K a source
(hm = 1486.6 eV) was used at a power of 210 W. The
analysis spot was 400 9 700 lm. The instrument resolu-
tion was 0.55 eV for Ag 3d and 0.70 eV for Au 4f peaks.
Survey scans were collected for binding energy from
1100 eV to 0 with analyzer pass energy of 160 eV and a
step of 0.35 eV. High-resolution spectra pass-energy was
20 eV with steps of 0.1 eV. The number of scans varied
from 8 to 60. Electron flooding was applied to compensate
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for sample charging. The binding energies of all samples
were corrected using 284.8 eV for the C1 s peak.
High-resolution Si spectra were modeled using Casa-
XPS (version 2.3.15, Casa Software Ltd.). The Si model
contained two components: one component representing
SiO, where the peak position, but not full-width at half
maximum (fwhm), was fixed at a value of 102.7 eV [32]. A
second component was represented via the addition of
another peak; this peak was left unconstrained and was
identified using data from the National Institute of Stan-
dards and Technology (NIST) X-ray Photoelectron Spec-
troscopy Database (http://srdata.nist.gov/xps/Default.aspx).
2.7 Plasma Adsorption
Platelet poor human plasma was obtained from the
Research Division of Canadian Blood Services and stored at
-80 C prior to its use. Bioactive glass materials were
added to 0.15 M phosphate buffered saline (PBS). In order
to compare protein adsorption results between the various
bioactive glass samples, surface area values for each system
were characterized using BET analysis (as outlined above).
That said, it should be recognized that (esp. for sol–gel
samples) BET results for surface area is directly relative to
the size of nitrogen and may significantly overestimate how
much surface area is accessible to protein for adsorption.
250 lL of each bioactive glass solution were mixed with
1.25 mL human plasma for a final plasma concentration of
83 %. Protein adsorption was conducted at 37 C for 2 h
under rocking agitation. Samples were spun down at
13,000 rpm (VWR galaxy 16DH, Mississauga, ON) for
10 min. Supernatant was replaced with 1 mL 0.15 M PBS,
left at room temperature for 30 min so as to remove loosely
bound proteins. This wash step was carried out twice.
Adsorbed protein was eluted from the bioactive glass
surface by incubating rinsed samples in 2 % w/v sodium
dodecyl sulfate (SDS) (J.T. Baker, Phillipsburg NJ) in
0.15 M PBS at 50 C for 2 h as described in [33]. Condi-
tions that yielded consistent and optimal protein removal
included looking at temperature variation (room tempera-
ture to 50 C) and solution SDS concentration (2–10 %).
The above strategy was found to be optimal (results not
shown). Eluent containing removed protein was collected
by centrifuging the samples, as described above. Finally,
all blood donors were fully informed (according to Cana-
dian Blood Services policy) and samples were pooled to
anonymize the donors.
2.8 Total Protein Assays
The DC Protein Assay from Bio-Rad (Hercules, CA) was
used to determine the concentration of eluted protein from
the bioactive glass samples. Recommended manufacturer’s
protocols were followed. Briefly, bovine serum albumin
(BSA) was used to generate standard curves in 2 % SDS
and 0.15 M PBS. The BSA control and 100 lL aliquots of
each solution of protein eluted from the bioactive glass
sample were analyzed using the protein assay kit compo-
nents, and a DU 730 Life Sciences UV/Vis spectropho-
tometer (Beckman Coulter, Mississauga, ON) was used to
read the absorbances at 740 nm. Each sample was assayed
in duplicate.
However, for some samples the total protein values
returned from this assay were near the assay’s lower limit,
questioning their accuracy. Thus, an alternative method
was developed based on colloidal gold staining [23], which
should have a significantly greater sensitivity to the protein.
3 lL from each bioactive glass sample was pipetted onto a
PVDF membrane (0.2 lm, Bio-Rad, Hercules, CA) and
allowed to air dry. The same was done with various known
quantities of BSA in the same buffer as the samples. The
membranes were then processed according to the Colloidal
Gold Total Protein Stain instructions (Bio-Rad, Hercules
CA). Briefly, the membranes were blocked with 0.3 %
Tween 20 in Tris-buffered saline (20 mM Tris and
500 mM NaCl) three times for 20 min each, rinsed with
Milli-Q Synthesis purified water (Billerica, MA) 3 times
for 2 min each, stained with colloidal gold solution
(Bio-Rad, Hercules, CA) for 1 h and finally rinsed again
with purified water 3 times for 1 min each. The membranes
were then scanned and the stain intensities, less back-
ground intensities, quantified using Adobe Photoshop
(Version 9, Adobe Systems Inc, San Jose CA USA). This
information, coupled with the calibration curve intensities,
yielded the total protein per sample.
2.9 SDS-PAGE and Western Blotting
As described previously [34], 30 lg of total eluted protein
from each bioactive glass sample was analyzed using
reducing SDS polyacrylamide gel electrophoresis (SDS-
PAGE) and Western blotting techniques. Briefly, protein
samples were reduced and denatured by the addition of
sample buffer which, when diluted, contained 0.5 M
b-mercaptoethanol and 2 % SDS. The sample and sample
buffer mixtures were then heated at 95 C for 5 min before
being run on 12 % SDS polyacrylamide gels at 200 V and
400 mA. Proteins were transferred from these gels to
0.2 lm Immuno-Blot PVDF membrane (Bio-Rad, Hercu-
les, CA) for 1 h at 100 V, 200 mA. All consumables and
equipment were purchased from Bio-Rad (Hercules, CA).
The membranes were then divided into strips for colloidal
gold staining or Western blotting. Table 1 lists the primary
and secondary antibodies used for Western analysis. The
antibodies were used without further purification at con-
centrations of 1:1000. 350 lL of stabilized TMB substrate
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(Promega, Madison, WI) was used to visualize all protein-
antibody complexes. The colour developing reactions were
allowed to progress until precipitation of the coloured
compound was observed (20 min for cast amorphous and
cast crystalline and 10 min for sol–gel). The reaction was
then quenched for 10 min with 2 mL of water from a
MilliQ Synthesis water purification system (Billerica, MA).
3 Results
3.1 Surface Area
Surface area measurements were performed on both the
melt-cast and sol–gel derived bioactive glasses in order to
determine if the surface areas per gram changed as a
function of the manufacturing method. It was found that
the melt-cast bioactive glass had a surface area of 5.9 m2/g
and the sol–gel has a surface area of 11.1 m2/g (95 %
reproducibility limit). That is to say, using the sol–gel
manufacturing method increased the surface area of the
bioactive glass by about a factor of 2. For the purposes of
this experiment it was assumed that devitrification of melt-
cast bioglass should not significantly change the surface
area of the material, relative to the factor of two change in
surface area realized for severe morphological differences
that exist between the sol–gel and melt-cast derived
materials.
3.2 SEM
The morphologies of the bioactive glasses are illustrated in
Fig. 1. Gel-derived 45S5 powder appears as agglomerates
of fine sub-micron particles and exhibits submicron
porosity (Fig. 1a). This leads to a higher surface area for
the gel-derived 45S5 compared to the other powders as
shown with the surface area results. Melt-cast samples
show similar particle morphology in either amorphous or
crystalline states (Fig. 1b, c), with crystalline powder
having slightly smoother surfaces and edges due to glass
softening at relatively high temperatures.
3.3 XRD
X-ray diffraction patterns are shown in Fig. 2. As
expected, no sharp peaks were detected on the amorphous







Kininogen (light chain) 50 6.6 Mouse US Biological, Swampscott, MA, USA
Kininogen (heavy chain) 88–120 6.8 Mouse US Biological, Swampscott, MA, USA
Factor I 88 7.6 Mouse Cedarlane Laboratories, Hornby, ON, CAN
Fibrinogen 340 6.6 Rabbit Calbiochem, Gibbstown, NJ, USA
Fibronectin 440 5.7 Rabbit Cedarlane Laboratories, Hornby, ON, CAN
Hemoglobin 68 8.0 Rabbit Sigma-Aldrich, St. Louis, MO, USA
a1-Antitrypsin 47 5.6 Sheep Cedarlane Laboratories, Hornby, ON, CAN
Thrombin 36 5.4 Sheep Cedarlane Laboratories, ON, CAN
Prothrombin 72 5.9 Sheep Cedarlane Laboratories, ON, CAN
Protein C 62 6.3 Sheep Cedarlane Laboratories, ON, CAN
Vitronectin 75 5.8 Sheep Cedarlane Laboratories, ON, CAN
Protein S 69 5.7 Sheep Cedarlane Laboratories, ON, CAN
Prekallikrein 85 8.2 Sheep Cedarlane Laboratories, ON, CAN
Antithrombin 53 6.7 Sheep Cedarlane Laboratories, ON, CAN
IgG 174 8.4 Goat Sigma-Aldrich, St. Louis, MO, USA
Human albumin 66 6.8 Goat OEM Concepts, Saco, ME, USA
Plasminogen 90 7.3 Goat Cedarlane Laboratories, ON, CAN
Complement factor 3 (C3) 185 6.4 Goat Calbiochem, Gibbstown, NJ, USA
Factor XII 80 7.7 Goat Cedarlane Laboratories, ON, CAN
Factor XI 160 8.1 Goat Cedarlane Laboratories, ON, CAN
Apolipoprotein A1 28 7.1 Goat Sigma-Aldrich, St. Louis, MO, USA
Transferrin 77 7.1 Goat Sigma-Aldrich, St. Louis, MO, USA
a2-Macroglobulin 718 6.4 Goat Sigma-Aldrich, St. Louis, MO, USA
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45S5 given its structure; confirmed by the presence of a
broad peak at *32 2h. The XRD patterns of the crys-
talline samples matched that of combeite—a crystalline
sodium-calcium-silicate phase (Na2Ca2Si3O9, PDF#075-
1687) commonly formed upon devitrification of 45S5
bioactive glass.
3.4 Surface Charge
Zeta potential measurements were conducted on pristine
samples to determine the surface charges of the various bio-
active glass materials (Table 2). It was observed that all of
these materials, regardless of crystallinity or manufacturing
conditions, exhibited similar surface charges ranging from
-14 to -17 mV. A Student’s t test for significance showed
that these systems were not statistically different although cast
crystalline sample appears to have a difference in surface
charge compared to the sol–gel and cast amorphous.
3.5 Surface Properties: X-ray Photoelectron
Spectroscopy (XPS) Results
XPS was performed on all systems, both prior to and after
incubation in platelet poor human plasma (Table 3).
Fig. 1 Secondary electron
SEM micrographs of
a crystalline gel-derived 45S5,
b amorphous melt-cast 45S5,
and c crystalline (devitrified)
melt-cast 45S5. Notice the
agglomerated particles in the
gel-derived specimen (a) which
gives rise to submicron porosity,
whereas the melt-cast glasses in
(b) and (c) have much smoother
surfaces. Upon heat treatment to
change from state (b) to (c) the
glass devitrifies and the sharp
angular fractured surfaces
smoothen slightly due to glass
softening at 720 C
Fig. 2 XRD patterns of melt-cast and gel-derived 45S5 powders. The
as cast melt-cast glass is amorphous (showing a broad bump at *32
2h and no sharp peaks corresponding to crystallographic planes).
When the cast glass is intentionally crystallized the peaks that are
observed match those of combeite (Na2Ca2Si3O9), the same phase
which is observed after gel-derived 45S5 is thermally stabilized and
crystallized
Table 2 Surface charges of bioactive glass constructs before incu-
bation with human plasma (n = 3)
System Surface charge (mV)
Sol–gel -14.3 ± 3.5
Cast amorphous -14.8 ± 2.9
Cast crystalline -17.1 ± 1.5
Data represent mean ± 1 SD
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Pristine bioactive glass samples showed high levels of
carbonaceous contamination, a situation that has previously
been reported in the literature for similar systems [35]. The
ill-defined layer of contaminating carbon ultimately
decreases the atomic percentages of all the other elements,
a trend observed for all pristine samples when compared to
the theoretical composition. It has been previously shown
that carbonaceous contamination may contain oxygen as
well, so in order to better understand the bioactive glass
surface, the atomic percentages of both carbon and oxygen
were removed and the remaining values normalized
(Table 4).
High resolution XPS for both Si and P were analyzed.
However, the variety of binding energies present for P
made it impossible to independently determine its binding
environment. A similar issue existed for Si, whereby a
plethora of SiOx binding energies have been reported in the
literature (ranging from 99.3 to 103.6 eV) [36]. However,
the binding energy for SiO was 102.0 eV specifically.
Therefore, elucidation of the Si (2p) binding energies was
possible; one peak was constrained to represent SiO and a
second peak was used to represent the general SiOx
binding energies (Table 5). Complimentary to this, a
minimum number of peaks were used to fit the high reso-
lution Si data; the reduction of the degrees of freedom in
the model, while returning similar fits, being thought to be
the most accurate means of modeling this data. Using this
strategy for peak fitting of the high resolution Si data, it
was observed that all pristine bioactive glass surfaces had
virtually no SiO present. The entire Si (2p) peak could be
fit using binding energies relative to SiOx. This might be
expected, as it has been discussed in the literature that SiO
may be formed only transiently during the early stages of
biomineralization [37]. After incubation in plasma both the
cast crystalline and sol–gel samples did show some SiO on
their surfaces. The presence of SiO on these surfaces but
not on the amorphous bioglass suggests that the crystalline
samples undergo biomineralization at a slower rate than the
amorphous bioactive glass. This increase in reaction time
of crystallized bioactive glass is consistent with the liter-
ature [10–12].
3.6 Protein Adsorption: Amount Adsorbed
Bioactive glass samples were incubated with platelet-poor
human plasma for 2 h at 37 C and any loosely bound
proteins were removed by washing twice with PBS. Rinsed
bioactive 45S5 powders were incubated in SDS solutions
(final 2 % concentration) and eluents were analyzed for
total protein concentration. From the XPS results summa-
rized in Table 3, after incubation in plasma, multiple buffer
rinses and the SDS elution step, it was evident that there
were only trace amounts of residual N and S on some of the
samples.
The total amount of plasma proteins adsorbed to the
various bioactive glass systems were determined using two
Table 3 Summary of the
atomic percentages of bioactive
glass systems before and after
incubation with human plasma
Values are accurate to less than
±10 %
System Na O Ca P Si N C S
Theoretical (atomic %) 17.3 55.2 9.5 1.8 16.3
Before solution incubation
Sol–gel 9.5 45.7 3.2 0.5 10.7 30.1
Cast amorphous 8.9 40.9 2.7 1.3 6.1 39.8
Cast crystalline 7.8 49.1 4.8 0.5 12.3 25.3
After solution incubation
Sol–gel 4.5 46.9 7.7 3.6 7.0 29.1 1.1
Cast amorphous 10.7 34.2 2.9 0.8 2.1 1.4 46.6 1.4
Cast crystalline 6.8 53.8 8.9 4.7 8.0 17.3
Table 4 Summary of the
atomic percentages of various
bioactive glass systems before
and after incubation with human
plasma after removing C and O
values and normalizing
Values are accurate to less than
±10 %
System Na Ca P Si N S
Theoretical (atomic %) 38.5 21.2 3.9 36.4
Before solution incubation
Sol–gel 39.7 13.5 2.1 44.7
Cast amorphous 46.8 14.2 6.8 32.2
Cast crystalline 30.6 18.8 2.0 48.6
After solution incubation
Sol–gel 18.8 32.0 15.0 29.1 4.7
Cast amorphous 55.5 15.0 4.1 10.9 7.3 7.2
Cast crystalline 23.5 30.8 16.1 27.8
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independent methods: the common DC protein assay and
an in-house nanogold based assay. DC and nanogold pro-
tein assay results are summarized in Table 6 and Table 7,
respectively. The nanogold assay was specifically devel-
oped to utilize the nanogram sensitivity that Au nanopar-
ticles exhibit for protein, facilitating the quantification of
low concentration protein solutions. It is well known that
although the DC assay overcomes the issues associated
with the presence of SDS in a protein solution, protein
concentrations below *0.2 mg/mL (2 % SDS) cannot be
accurately detected. Although complicated strategies can
be employed for concentrating the protein in solution, a
more direct and convenient methodology for directly
measuring protein concentration has been employed [23].
Herein, this nanogold assay was shown to be appropriate
for quantifying the amount of protein in a concentration
range almost five times less that of the minimum detectable
concentration of the DC assay, viz., *0.04 mg/mL.
3.7 Protein Adsorption: Adsorbed Proteome
Eluted protein solutions from the various bioactive glass
samples were subject to SDS-PAGE and immunoblotting
analysis in order to identify the composition of the adsor-
bed protein layer. In order to facilitate the comparison of
band intensities between different systems, a constant
quantity of protein (30 lg), as well as constant times for all
colour development steps, were used for all systems. This
also removes any specific surface area variations when
comparing samples. By keeping these conditions constant
between samples it is possible to compare the intensities of
the immunoblot bands between samples, for the same
protein, to determine the relative amount of each protein
that was eluted from the bioactive glass surfaces. Table 7
summarizes the band intensity data for all samples. A 13
step grayscale was used to quantify the band intensity. The
number 12 indicate a fully black band, or the highest
intensity band, and lower numbers mean decreased band
intensity. A value of zero indicates no band was present.
Moreover, it is not possible to compare between band
intensities of different proteins, as each protein may ‘label’
differently. Thus, only comparisons can be drawn between
the intensities of like proteins. It should also be highlighted
that although these techniques can detail the composition
of the adsorbed protein layer, they do not provide insight
into the conformation of the adsorbed proteins themselves.
Recently, it has been shown that it is not only the adsorbed
protein content, but also the conformation of the adsorbed
proteins that can facilitate further cellular interactions [40].
The results of the SDS-PAGE of the eluted plasma
proteins for each bioactive glass sample seemed quite
similar (results not shown). Each of the samples yielded a
very intense band at *66 kDa and a moderately intense
band at *50 kDa. These bands are thought to be at least
partially made up of albumin and alpha1 antitrypsin,
respectively. A band at *25 kDa was also visible for each
sample, being most intense for the sol–gel system, then the
Table 5 Summary of high resolution modeling of Si (2p) for bioactive glass samples before and after incubation in plasma













Sol–gel 0 0 100 99.8 1.8 Si [38]
Cast amorphous 0 0 100 99.8 2.0 SiOx/Si [38]
Cast crystalline 0 0 100 100.9 3.0 SiOx [39]
After plasma incubation
Sol–gel 5.5 1.7 94.5 100.2 1.9 SiOx [39]
Cast amorphous 0 0 100 100.7 2.1 SiOx [39]
Cast crystalline 25.4 3.1 74.6 100.5 2.0 SiOx [39]
Values are accurate to less than ±10 %






Cast amorphous 0.157 ± 0.004 0.53 ± 0.01
Cast crystalline 0.169 ± 0.01 0.57 ± 0.03
Sol–gel 0.082 ± 0.005 2.46 ± 0.2
Values represent average ± 1 SD (n C 3)






Cast amorphous 0.140 ± 0.007 0.47 ± 0.02
Cast crystalline 0.151 ± 0.007 0.51 ± 0.02
Sol–gel 0.045 ± 0.007 1.35 ± 0.2
Values represent average ± 1 SD (n = 3)
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cast amorphous and least for the cast crystalline systems.
Faint banding was also visible at *35 kDa. In general
though, the degree of banding and their intensities in the
SDS-PAGE results imply that there were comparable




Surface area measurements indicate twice the surface area
per unit mass of powder for sol–gel derived powders
compared to melt-cast powders. Based on the manufac-
turing route, a higher surface area for sol–gels, as their
structure is built through condensation of Si–O bonds,
leaving behind precursor chemicals which then evaporate
leaving pores. The higher specific surface area values for
sol–gel powders indicates that the surfaces of such powders
should be more tortuous, or more porous than their cast
counterparts, which is indeed what was observed in
microscopy.
4.2 Sem
SEM confirmed that the powder surface morphology, at
least on a micron length scale, was very different between
sol–gel and cast powders. The sol–gel powders appear to
be agglomerates of submicron particles that have not fully
come into contact, thus leaving an internal pore structure
on the submicron length scale. The larger melt-cast parti-
cles in Fig. 1b and c have smaller powder particles stuck to
their surfaces, which also generate regions resembling
pores.
With respect to the melt-cast amorphous powder, the
weak interaction of smaller powder particles to the surface
may or may not be stable in solution, so it is not possible to
predict if the specific surface area changes upon immer-
sion. The devitrified melt-cast and stabilized sol–gel
powders were exposed to relatively high temperatures
(close to the softening temperature/point) so it is reason-
able to assume that the powders have fused together with
sufficient strength to withstand immersion.
The SEM micrographs also indicate that there is as
associated surface roughness on all powder particles. The
roughness was not quantified, but judging from the
micrographs in Fig. 1 it is possible to see variations in
surface roughness of individual particles between the
powders; devitrified melt-cast appears smoother than as
cast melt-cast powder, and similar to sol–gel powder.
Again the thermal treatments likely play a role in the
similarity between devitrified melt-cast and sol–gel
powders. Interpretation of fine scale roughness, or
smoothness, is not a simple task, and was not undertaken in
this work. However, it should be noted that a smoother
looking surface could potentially have higher microporos-
ity than a rougher looking surface at low magnifications—
the fine scale surface morphology would need to be
quantified in order to make any claims about differences
between all the powders studied herein in order to shed
light on potential implications for porosity on the length
scale relevant for proteome adsorption (i.e., nanometer
scale). Nonetheless, based on surface area measurements,
with gas molecules small enough to penetrate nanometer
scale pores, the differences between the powders do not
seem great enough to imply large differences in fine scale
microporosity on the surfaces of the powders, hence our
limited investigation of small scale surface properties.
4.3 XRD
XRD was used to verify the structure of the various pow-
ders. The broad peak of the amorphous melt-cast powder
indicates that there is no repeating long range order within
the glass, and hence there will necessarily be a distribution
of bond lengths within the material. For crystalline pow-
ders such as devitrified melt-cast powder and sol–gel
derived powder the patterns match combeite (Na2Ca2-
Si3O9), which has a trigonal-trapezohedral class symmetry.
A major implication in the formation of combeite crystals
in both devitrified powders is that combeite is a calcium
sodium silicate and should not contain any phosphorous. If
phosphorous was rejected from the combeite crystals as
they grew, then a gradient in phosphorous could be gen-
erated between the crystals and their grain boundaries, or
the phosphorous could volatilize. Previous work has sug-
gested that some phosphorous is still present in a grain
boundary phase with different aqueous solubility [17]. XPS
analysis suggests that phosphorous content is lower in the
crystallized powders (Table 4), which could imply that
some of the phosphorous has volatilized, and that some
remains in the grain boundary phase. Regardless, the
phosphorous effect is likely not significant; similar XRD
patterns and surface chemistry (XPS) between crystalline
powders does not result in similar protein adsorption pro-
files, thus the surface morphology, or more subtle varia-
tions in surface chemistry may play a more dominant role.
4.4 Surface Charge: Zeta Potential
The zeta potential results differ from those reported by
El-Ghannam et al. [41] where they show that for cast
amorphous 45S5 bioactive glass as little as 5 % crystalli-
zation of cast amorphous bioactive glass leads to a statis-
tically significant change in zeta potential. It should be
Biointerphases (2012) 7:41 Page 9 of 15
123
noted that in the study performed by El-Ghannam et al. the
bioactive glass particulates were suspended in simulated
body fluid, which may alter the surface properties.
4.5 Surface Properties: XPS
It is apparent that substantial differences existed between
the fractional amount of various elements predicted by the
overall atomic composition of the bioactive glass samples
and the atomic compositions determined at the surface
region using XPS techniques. Theoretically, all bioactive
glass samples should have similar surface compositions;
however, it was observed that the surface regions had
somewhat unique atomic profiles. In general, the pristine
sol–gel surface was enriched by *23 % in Si, compared to
the theoretical content, while being depleted by *36 and
46 % in Ca and P, respectively (Table 4). These are
obviously substantial differences in the surface content of
the sol–gel materials. The surface of the pristine cast
amorphous sample showed an enrichment of *22 and
74 % in Na and P specifically, while exhibiting a reduction
of *33 % in Ca. Upon crystallization, however, cast
crystalline samples were observed to be enriched
by *34 % in Si and reduced by *20 and 49 % in Na, and
P, respectively.
The crystallization of 45S5 bioactive glass seemed to
have dramatic effects upon the atomic composition of the
surfaces. For example, when comparing the cast amor-
phous to cast crystalline it is apparent that the levels of Na
and Si are almost exactly reversed. The cast crystalline
having *49 % of the surface composed of Si, while the
amorphous material exhibiting *47 % of the surface
being Na. Also of interest is the apparent difference in P,
where the amorphous layers had more than three times the
P than either crystalline material. Moreover, it seems that
the surface compositions of the cast crystalline and crys-
talline sol–gel were somewhat similar: both showed enri-
ched amounts of Si, and similar amounts of P. The only
substantial differences being that the sol–gel surfaces
retained more Na and less Ca than the cast crystalline
samples. Currently there are very few XPS measurements
for the sol–gel derived bioactive glass, making it difficult
to compare these results to the literature.
The pristine bioactive glass elemental composition data
only somewhat resembles the XPS data for the cast
amorphous 45S5 bioactive glass found in the literature
[35, 42] most likely due to the differences in the amounts
and thicknesses of C and O contamination and their effects
on the atomic concentration calculations and the penetrat-
ing power of the XPS itself. Chen et al. had C and O levels
of 49.6 % and 24.8 % respectively and Mladenovic et al.
found C levels of 12.3 % and O levels of 66.05 % on their
respective cast amorphous 45S5 bioactive glass. Not only
are these values different from those shown in Table 3 and
from one another, the levels of Na, Ca, P and Si reported in
[35, 42] also vary a considerable degree. Chen et al. report
atomic concentrations of 0.88, 4.63 and 4.03 % for Na, Ca
and P respectively while Mladenovic et al. found their
surfaces composed of 16.27, 2.91 and 0.25 % Na, Ca and
P.
It is well known that the incubation of bioactive glass
samples (amorphous) in various ‘physiologically relevant’
solutions (i.e., simulated body fluid) leads to the first steps
of biomineralization, as aptly reviewed elsewhere [9].
From this work, it is also apparent that incubation in
platelet-poor human plasma affected the surface composi-
tion of each of the bioactive glass samples. Upon com-
paring the pristine sol–gel with the same samples after
incubation in plasma it is apparent that drastic differences
in all atomic concentrations occurred. After incubation the
sol–gel surface layers experienced respective reductions
of *52 and 35 % in Na and Si content. Conversely, the
sol–gel surfaces experienced drastic increases of *2 and 7
times for Ca and P content. These changes in surface
chemistry correlate with the sequence of events which
occur on bioactive glass surfaces during bone bonding [9].
The apparent reduction in Na? is more accurately descri-
bed as an exchange of cations with H? or H3O
? from
solution. The decrease in Si is consistent with the loss of
soluble SiO2 species and the large increases in surface Ca
and P match the composition of naturally grown apatites
and indicate the first step of hydroxyapatite formation [9].
Lastly, the presence of S atoms was most likely due to
remaining sodium dodecyl sulfate (SDS), which was used
as a detergent to strip proteins off of these surfaces. Cast
amorphous surfaces, however, did not exhibit a drastic
alteration in atomic concentrations. Only moderate changes
in Na and decrease in P were observed, most likely within
the error of the characterization technique. However, a Si
decrease of *60 % occurred. Again this is consistent with
the dissolution of SiO2 seen in the sol–gel sample but could
also indicate that the XPS is not penetrating far enough into
the material to reach the Si rich layer as shown in [9]. This
could be explained by the presence of an N and S signal for
these samples, suggesting the presence of protein and the
potential presence of SDS. This adsorbed layer of bio-
molecules could inhibit the signal intensity of the bioactive
glass surface atoms. Cast crystalline surface alterations
were very similar to those observed for the sol–gel surface,
showing drastic increases of *2 and 7 times the amount of
Ca and P, respectively, and a decrease of *43 % in Si as
well. As with the sol–gel bioactive glass, the decrease in Si
may be indicative of the loss of soluble SiO2 species and
the large increases in Ca and P suggest the accumulation of
the chemical moieties necessary for hydroxyapatite for-
mation [9]. Although not guaranteed, in this case it would
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seem a complete removal of SDS and protein occurred, as
evidenced by the lack of N and S signal. Moreover, it was
apparent that the two crystalline materials underwent very
similar changes in their surface chemistry and those
changes were not consistent with those seen for the cast
amorphous bioactive glass.
In order to further understand the state of the surface, it
is important to consider the steps of interfacial reactions
that are thought to occur in solution after 3 h incubation in
platelet poor human plasma. Previous work has detailed the
sequence of reactions at the bioactive glass surface [9].
Briefly, bioactive glasses first experience dissolution of
Na? and/or K? with H? or H3O
? in solution. Silanol
(SiH3OH) formation is thought to occur next, in conjunc-
tion with the release of soluble SiO2. These silanol groups
undergo further polycondensation, and the material begins
to adsorb amorphous phosphates, calcium and carbonate
groups from solution. These groups then undergo crystal-
lization to form hydroxyl carbonate apatite. These first
steps taking place within the first 2 h of solution incubation
for amorphous 45S5 bioactive glass [9]. The next step is
adsorption of biological moieties to the newly formed
hydroxyl carbonate apatite layer. This step is thought to
occur as early as the polycondensation of silanol groups
and continues throughout crystallization until the action of
macrophages is observed after *15 h solution incubation.
Upon comparison of the changes in surface composition
data of the cast crystalline and sol–gel samples as well as
the results of the Si modeling to the same timeline of
surface reaction it can be said that the increases in surface
Ca and P suggest that the first steps of biomineralization
have been completed and the materials were most likely
adsorbing amorphous Ca, PO4 and CO3 [9]. Furthermore,
the SiO found on the same surfaces means that both the
sol–gel and cast crystalline samples are still undergoing
polycondensation of SiOH and adsorption of Ca and P as
discussed above. Determining the position of the cast
amorphous bioactive glass on the timeline was more dif-
ficult in that the XPS data only showed a decrease in Si and
increases in S and N after incubation in plasma. The lack of
detectable SiO on the surface of the cast amorphous sample
could mean that the sample has not undergone any surface
biomineralization reactions or that is has moved beyond the
polycondensation step. As discussed above, the decrease in
Si could be attributed to SiO2 dissolution or may be a result
of changes in the surface profile of the sample as adsorp-
tion of hydroxyl carbonyl apatite components occurred. At
hour 3 of the interfacial reaction timeline the adsorption of
the components of hydroxyl carbonyl apatite has ceased
and the crystallization of these components is complete.
The primary active process is the adsorption of various
biological entities, such as proteins, to the newly formed
hydroxyl carbonyl apatite layer. This may be reflected in
the results by the presence of N and S, elements indicative
of proteins. Furthermore, the similarity of the Si signals for
cast amorphous bioactive glass before and after incubation
is consistent with what has been observed the literature
[43].
When the positions of the three bioactive glass samples
on the interfacial reaction timeline are compared to each
other it is clear that this series of experiments demonstrates
that all bioactive glass samples have begun biominerali-
zation with the cast amorphous sample progressing at the
rate predicted in the timeline for a 3 h incubation and the
cast crystalline and sol–gel samples lagging behind. This is
consistent with the findings of Filho et al., which state that
crystallization of 45S5 bioactive glass slows the rate of
surface reactions but does not completely halt them [44].
4.6 Protein Adsorption: Amount Adsorbed
When considering the adsorbed amounts calculated, it is
imperative that the surfaces areas were determined using
B.E.T. gas (N2) adsorption. Given the probability that
surfaces accessible to this gas may not be accessible to
proteins, makes it very difficult to accurately determine the
amount adsorbed per unity surface area. Nevertheless, this
strategy was adopted due to the fact that it is unknown how
much of this surface area is accessible to the solvent and
available for protein interactions. In general, when near the
lower concentration limit of the DC assay (*0.2 mg/mL),
both the DC and colloidal gold assays yielded similar
concentrations. However, a large difference occurred when
attempting to quantify protein concentrations lower than
the suggested minimum for the DC assay. The DC assay
showed, for the sol–gel prepared surfaces, a total protein
concentration almost twice as large as the nanogold assay
technique. It is thought that this difference was largely due
to the inaccuracy of the DC assay at this concentration.
Nevertheless, it is apparent that the cast amorphous and
cast crystalline samples had similar amounts of protein
removed from their surfaces and that these values were at
least double that of the amount adsorbed to the sol–gel
sample before considering the specific surface area of the
samples. When the amount of surface area of each sample
is taken into account, the relationship is then inverted and
the sol–gel bioactive glass eluted more protein per unit
mass than the cast samples. These results show that the
devitrification of melt-cast 45S5 does not play a significant
role in the adsorption of plasma proteins as both the cast
amorphous and cast crystalline samples eluted similar
quantities of protein. Data in Table 3 suggests the elution
procedure may not have been 100 % complete as based on
the atomic percentages of nitrogen and sulphur. Despite
these values being only approximately 1 %, it is probable
that they represent both retained protein (N and S) and/or
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SDS (S) on the material surface. However, due to their low
levels and the lack of consistent trend in the C or O
amounts, the amount of trace protein left at the powder
surface was thought to be minimal.
4.7 Protein Adsorption: Adsorbed Proteome
Elucidating the underlying reasons for the presence of dif-
ferent proteins screened for using immunoblot techniques is
not a trivial task. The complexity of the surface, relative to
the diversity of the proteins in solution makes it almost
impossible to attribute a proteins presence at the interface due
to charge differences between the protein and surface only. In
reality, proteins adsorbed to the interface may facilitate fur-
ther protein adsorption. This is compounded further due to
the fact that bioactive glass, upon immersion into plasma, has
been shown to have a transient interfacial composition. Thus,
the best that can be done is to understand the types of proteins
present, their relative amounts, and potential influence for the
various bioactive glass preparations.
The data in Table 8 shows a clear difference in the
identities of the proteins adsorbed to either crystalline 45S5
samples. This change in protein profile cannot be attributed
to the difference in specific surface area as identical
amounts of eluted protein were used in the Western anal-
ysis. Furthermore, given the very high sensitivity of the
Western blotting technique it is unlikely that any plasma
proteins present would not be detected. Thus the only
reason for such a large variation in plasma protein
adsorption between crystalline 45S5 samples would be
their surface compositions, or surface morphology, both of
which could affect protein conformation.
After albumin has been denatured and reduced during
sample preparation for SDS-PAGE the protein runs as a
single band with a molecular weight of 66 kDa. Albumin
was found to be in the eluted protein solutions for all
samples. Moreover, the band intensities indicated that
albumin was present at a similar amount for all samples
studied; with the cast amorphous sample potentially
adsorbing less than both cast crystalline and sol–gel sam-
ples. From this data, it is also apparent that even though
there was more protein adsorbed in total to the cast sam-
ples, the protein layer present for these systems was largely
composed of albumin. In the case of cast crystalline this
was the only protein that was observed to be present, and
cast amorphous this was one of only two proteins observed:
out of the 23 proteins screened. The presence of albumin is
somewhat expected due to its high plasma concentration,
but it is of particular interest due to the fact that it has been
reported that denatured albumin can lead to platelet
adsorption and activation [40]. This is particularly impor-
tant, as activated platelets are commonly used for bone
formation strategies [45].
Complement refers to a portion of innate immunity that
when activated can cause opsonization, an increased anti-
body response and lysis of cells [46]. As it is a response to
foreign bodies and materials, complement activation can
have serious consequences for biomaterial effectiveness
and overall host health [47]. Central to each of the three
complement activation pathways is complement Factor 3
(C3) [46]. It is composed of a (115 kDa) and b (72 kDa)
peptide chains, respectively. If complement is activated
and C3 cleaved, a band at 42 kDa becomes apparent [46].
Given this, it was apparent that the different surfaces
adsorbed varying amounts of C3 and showed differences in
activation of the complement pathway. The sol–gel sample
showed high levels of all of the C3 fragments, indicating
that this surface strongly adsorbed and activated C3; pos-
sibly indicating this surface may illicit a strong immune
response. The cast amorphous system showed less amounts
Table 8 Relative intensities for
immunoblots of plasma proteins
eluted from all of the bioactive
glass systems investigated
0 indicates zero band intensity.
The number 12 indicates the
highest intensity band, with









Cast amorphous Cast crystalline Sol–gel
Albumin 66 9 12 12
C3 42 Activation 4 0 9
70 b 8 1 12
115 a 3 0 12
IgG 27 Light 0 0 4
55 Heavy 0 0 1
Alpha1 antitrypsin 47 6 1 11
Fibrinogen 48 c 0 0 0
56 b 0 0 9
68 a 0 0 9
\48 Cleavage 0 0 0
Transferrin 77 0 0 11
Antithrombin 53 0 0 9
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of adsorbed and activated C3, but more than cast crystal-
line samples. The cast crystalline sample was found to have
almost no detectable C3 on its surface. Only a small
amount of the b chain was found. This information may
imply that the cast crystalline samples will not strongly
activate complement in vivo, while the other two samples
may.
Immunoglobulin G (IgG) is an antibody involved in host
immune response that, upon binding to an antigen, can
cause opsonization and phagocytosis and complement
activation via the classical pathway [46]. IgG normally
runs as two bands: the heavy chain at 55 kDa and the light
chain at 27 kDa. Neither the cast amorphous nor cast
crystalline samples appeared to have any IgG on their
surfaces. However, this protein was found eluted off of the
surface of the sol–gel system. Although IgG was detected,
other critical molecular markers for indicating a potential
immune response were not observed to be present. For
example, the lack of Factor I may indicate that although
IgG was present, the classical activation pathway may not
be initiated (Table 7). Of course, this does not rule out the
possibility of IgG opsonization, and potential phagocytosis
or fibrous capsule formation occurring due to the presence
of IgG; as previously observed for cast 45S5 bioactive
glass systems implanted into the thigh muscles of Sprague–
Dawley rats [48].
Alpha1-antitrypsin is considered to be one of the most
important serine proteases in the body [49] and is respon-
sible for maintaining anti-inflammatory response (especially
in protecting connective tissues). Normally, alpha1-anti-
trypsin appears as a single band at *52 kDa. In general, this
plasma protein was found to elute off of all of the tested
samples. The cast crystalline sample showed the least
amount of the protein, followed by the cast amorphous.
The sol–gel sample had the highest amount of alpha1-
antitrypsin found in the adsorbed protein layer. Given that
alpha1-antitrypsin has a charge of -12 at a pH of 7.0, it
might not be expected that its adsorption to negatively
charged bioactive glass should be observed. However, two
possible mechanisms may allow for this to occur. Firstly,
this protein is a part of the adsorbed protein layer, and may
interact with already adsorbed protein as opposed to
directly interacting with the surface. Secondly, the com-
position of the surface of the bioactive glass is transient as
it incubates within the plasma solution.
Fibrinogen’s a, b and c chains appear as three bands
with molecular weights of 68, 56 and 48 kDa, respectively.
Bands at lower molecular weights can appear when
fibrinogen is cleaved. The sol–gel bioactive glass is the
only sample from which any fibrinogen was eluted. While
the lack of fibrinogen degradation products may seem to be
a positive sign in that the surface does not appear to
stimulate fibrin formation, adsorbed fibrinogen has been
shown to denature to the point where it resembles fibrin or
fibrinogen degradation products [50]. Additionally adsor-
bed fibrinogen can activate platelets [51] and has been
shown to cause the accumulation of phagocytes [52], which
fight infection.
Transferrin is primarily responsible for the transport of
iron [53], and when run on a reduced SDS-PAGE gel it
forms a single band with an approximate molecular weight
of 75 kDa [53]. Transferrin was found exclusively on the
surface of the sol–gel sample. Based on its relative band
intensity, a large amount of transferrin was removed from
the bioactive glass surface. Given that the protein does not
contain a large number of charged residues it can be pre-
sumed that the transferrin was not adsorbed due to charge–
charge interactions.
Antithrombin is a serine protease inhibitor and while not
limited to acting on thrombin it is one of the most impor-
tant proteins responsible for limiting irregular clotting [54].
This protein appears as a single band at approximately
53 kDa when run on an SDS-PAGE gel. It was found on
the sol–gel bioactive glass in fairly high amounts as
determined by the relative band intensity. As was the case
with transferrin this protein is not charged and was only
found on the sol–gel bioactive glass. Given that both the
sol–gel and cast crystalline bioactive glass samples are
crystalline and have similar surface compositions (Table 3)
some characteristic imposed upon the sol–gel sample dur-
ing its manufacturing appears to be the cause of anti-
thrombin adsorption. When comparing to the XPS data, it
seems that antithrombin’s adsorption differences between
these samples cannot be due to the biomineralization pro-
cess, for if it were it should be found on both the cast
crystalline and sol–gel samples as they are at roughly the
same place in their maturation.
The absence of proteins from the bioactive glass sur-
faces can provide just as much information as the proteins
found on the surface. When comparing the list of proteins
found on the various bioactive glass surfaces (Table 7) to
the table listing all of the proteins which were scanned for
(Table 1) there are a large number of important plasma
proteins which were not found on any of the surfaces. Of
significance is the lack of any common cell adhesive pro-
teins (i.e., fibronectin and vitronectin) being present on the
surfaces. The presence of fibronectin has never been found
on the surfaces of pristine bioactive glasses [55]. As for
clot formation, Factor XI, Factor XII, prekallikrein and
high molecular weight kininogen are all absent. These
contact phase coagulation proteins are involved in the
initiation of the extrinsic coagulation cascade. Their lack of
detection may indicate that none of the samples may
activate coagulation through the contact phase. Neither
prothrombin nor thrombin was found on the surfaces of any
of the bioactive glass samples. This is another strong
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indication that these surfaces do not stimulate coagulation
given thrombin’s central role in this process [54]. Fur-
thermore, the lack of these proteins in conjunction with
protein C and protein S indicates there is no strong anti-
coagulant activity caused by the bioactive glass samples.
Also, the absence of a2-macroglobulin, a potent inhibitor
for both clotting and fibrinolysis, further strengthens the
hypothesis that the bioactive glass surfaces do not stimulate
either clot formation or breakdown. These are generally
considered a positive attribute for implanted biomaterials
to have, as the lack of these molecular level markers for the
activation of the coagulation cascade may indicate a lack of
clot formation.
While the consequences of the adsorption of specific
plasma proteins on cellular responses such as osteoblast
differentiation, viability and proliferation are beyond the
scope of this study, it has been demonstrated that a mul-
titude of factors influence plasma protein adsorption and,
by extension, host response. This has been unwittingly
demonstrated in the literature by the varied responses of
osteoblasts to Class A bioactive materials. The effects of
these materials have ranged from very positive to inhibi-
tory [23–27]. Given that these studies did not use identical
circumstances or times, they also would not have elicited
identical responses from the plasma proteins directing host
responses.
5 Conclusions
In this study bioactive glass 45S5 was produced in various
forms using differing methods and evaluated for their
physical characteristics and interactions with platelet poor
human plasma. Commercially and medically employed
melt-cast 45S5 was compared with devitrifed crystalline
melt-cast 45S5 as well as sol–gel produced crystalline
45S5. These modifications in bioactive glass synthesis
were imparted to produce glasses with better physical
properties. Devitrification of melt-cast 45S5 leads to
improved mechanical properties while enabling powder
sintering and using the sol–gel method produces a porous
crystalline glass with a higher specific surface area to
encourage interactions with the surrounding environment.
It was found that sol–gel derived 45S5 showed higher
surface area and submicron porosity in the structure com-
pared to either of the melt-derived glasses. This in turn led
to increased plasma protein adsorption both in terms of
quantity and in variety of the adsorbed proteome. The
presence of IgG and fibrinogen on the sol-gel glass suggest
that this manufacturing method may lead to negative host
responses, namely immune and clotting responses. The
devitrification of melt-cast 45S5 changed the surface
composition as shown by XPS analysis but did not change
the amount of plasma protein adsorption; devitrification
did, however decrease the presence of C3 and alpha1
antitrypsin on the surface which may decrease any ten-
dency toward deleterious host responses. These differences
in surface structure obviously affect the adsorbed proteome
and may influence bone integration via mediating cell
attachment.
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